SCHEMBL17850527

SCHEMBL17850527

CC(C)C(=O)Nc1nnc(I)s1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.62
▸ CA1 P00915 1/20 0.57
▸ CA2 P00918 1/20 0.57
▸ CA4 P22748 1/20 0.57
▸ CA9 Q16790 1/20 0.57
▸ SMN1; SMN2 Q16637 2/20 0.55
▸ ALDH1A1 P00352 4/20 0.50
▸ NPC1 O15118 3/20 0.50
▸ KDM4E B2RXH2 3/20 0.50
▸ RAB9A P51151 2/20 0.50
▸ MEN1 O00255 1/20 0.50
▸ KMT2A Q03164 1/20 0.50
▸ HSD17B10 Q99714 2/20 0.48
▸ MAPT P10636 1/20 0.48
▸ CCNE1 P24864 1/20 0.47
▸ CDK2 P24941 1/20 0.47
▸ CDK5 Q00535 1/20 0.47
▸ RXFP1 Q9HBX9 2/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ GAA P10253 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9290603 0.79 POLB (0.66) TSHRCA1CA2CA4CA9
SCHEMBL9891787 0.75 KDM4E (0.70) TSHRCA1CA2CA4CA9
SCHEMBL11614784 0.74 FFAR2 (0.60) TSHRCA1CA2CA4CA9
SCHEMBL11049891 0.73 CA1 (1.00) CA1CA2CA4CA9SMN1; SMN2
SCHEMBL21325843 0.73 TSHR (0.55) TSHRCA1CA2CA4CA9
SCHEMBL17850506 0.73 CA1 (0.72) TSHRCA1CA2CA4CA9
SCHEMBL18552813 0.73 TSHR (0.55) TSHRCA1CA2CA4CA9
SCHEMBL12768097 0.73 TSHR (0.84) TSHRSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL9891908 0.71 NPC1 (0.63) TSHRSMN1; SMN2ALDH1A1NPC1KDM4E
SCHEMBL11617965 0.71 TSHR (0.54) TSHRCA1CA2CA4CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2643299-B1 BIPYRIDINE SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES OR CONDITIONS NOSCIRA SA (ES) 2016-06-22 — — EP disclosed
Send feedback